Conference
Abstract PO081: Systematic Generation of Allogeneic Immune-targeting Modalities for Glioblastoma
Abstract
Abstract
Glioblastoma (GBM) is one of the most common brain tumors in adults. Despite a standard-of-care including surgery and chemoradiotherapy, patients only live to a median of 15 months. This may be due to extensive spatiotemporal, intratumoral heterogeneity observed. This is thought to be created by a small population of stem-like cells marked by expression of CD133. CD133 has been shown to correlate with poor patient …
Authors
Salim SK; Wei J; Dimitrov V; Chen K; Venugopal C; Vora P; Moffat J; Singh SK
Volume
9
Pagination
pp. po081-po081
Publisher
American Association for Cancer Research (AACR)
Publication Date
February 1, 2021
DOI
10.1158/2326-6074.tumimm20-po081
Conference proceedings
Cancer Immunology Research
Issue
2_Supplement
ISSN
2326-6066